Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - BRAIN SCIENTIFIC INC. | f10q0321_brainscientific.htm |
| EX-32.1 - CERTIFICATION - BRAIN SCIENTIFIC INC. | f10q0321ex32-1_brainsci.htm |
| EX-31.2 - CERTIFICATION - BRAIN SCIENTIFIC INC. | f10q0321ex31-2_brainsci.htm |
| EX-31.1 - CERTIFICATION - BRAIN SCIENTIFIC INC. | f10q0321ex31-1_brainsci.htm |
| EX-10.5 - ALLONGE #2 TO CONVERTIBLE PROMISSORY NOTE IN FAVOR OF LEONARD MAZUR - BRAIN SCIENTIFIC INC. | f10q0321ex10-5_brainsci.htm |
| EX-10.4 - ALLONGE #2 TO CONVERTIBLE PROMISSORY NOTE IN FAVOR OF LEN P. MERTZ - BRAIN SCIENTIFIC INC. | f10q0321ex10-4_brainsci.htm |
| EX-10.3 - ALLONGE #2 TO CONVERTIBLE PROMISSORY NOTE IN FAVOR OF JOHN SILVESTRI - BRAIN SCIENTIFIC INC. | f10q0321ex10-3_brainsci.htm |
| EX-10.2 - ALLONGE #2 TO PROMISSORY NOTE IN FAVOR OF PROUDLIVING, LLC - BRAIN SCIENTIFIC INC. | f10q0321ex10-2_brainsci.htm |
Exhibit 32.2
Certification of Principal Financial Officer
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
I, Mark Corrao, Chief Financial Officer of Brain Scientific Inc., hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, the quarterly report on Form 10-Q for the period ending March 31, 2021 of Brain Scientific Inc. (the “Form 10-Q”) fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Brain Scientific Inc.
| Dated: May 24, 2021 | /s/ Mark Corrao |
| Mark Corrao | |
| Chief Financial Officer | |
| (Principal Financial and Accounting Officer) |